Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
The current Pfizer(PFE) stock price is $28.29, with a market capitalization of 161.22B. The stock trades at a price-to-earnings (P/E) ratio of 38.03 and offers a dividend yield of 5.99%.
On 2026-09-29, Pfizer(PFE) stock traded between a low of $28.26 and a high of $28.82. Shares are currently priced at $28.29, which is +0.1% above the low and -1.9% below the high.
The Pfizer(PFE)'s current trading volume is 10.79M, compared to an average daily volume of 34.78M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $29.21 and a 52-week low of $23.62.
In the last year, Pfizer(PFE) shares hit a 52-week high of $29.21 and a 52-week low of $23.62.
PFE News
Nurix Therapeutics (NRIX) announced the achievement of a $7M research milestone under its strategic collaboration with Pfizer (PFE) for the discovery and develo...
Pfizer (PFE Quick QuotePFE - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the fact...
Pfizer (PFE) is heading into its U.S. All Stars Conference appearance in London on 22 September 2026 with investors weighing its shareholder payouts, recent acq...
Analyst ratings
61%
of 28 ratingsMore PFE News
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer Inc. is quietly building new pillars of growt...
Key Points AbbVie is transitioning its revenue base toward newer immunology drugs to offset the decline of its legacy treatments. Pfizer is leaning on heavy i...
Pfizer (PFE) shares clocked seven straight sessions of gains, as the stock was up 1% at $28.68 on Friday. The global biopharmaceutical company gained 2.8% in t...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is launching a new study to test ponsegromab in adults with non-small c...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running a phase 3 study called “A Study to Learn About Revaccination...
Key Points Bristol Myers Squibb maintains strong positions in oncology and neuroscience with high free cash flow generation. Pfizer is undergoing a major tran...
BridgeBio Pharma (BBIO) on Wednesday announced that its heart disease therapy acoramidis, branded as Attruby in the U.S., outperformed Pfizer’s (PFE) rival drug...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.